β¨ Health Notices
3304 NEW ZEALAND GAZETTE, No. 127 22 NOVEMBER 2007
Health
Crown Entities Act 2004
Appointment to the Crown Health Financing Agency
Pursuant to section 28(1)(a) of the Crown Entities Act 2004, I have appointed
Andrew John Anderson (known as John Anderson)
as a member of the board of the Crown Health Financing Agency for a three-year term of office commencing on 13 November 2007 and expiring on 12 November 2010.
This appointment was made by way of written notice to the member (with a copy to the entity), pursuant to section 28(2) of the Crown Entities Act 2004.
Dated at Wellington this 12th day of November 2007.
HON. DAVID CUNLIFFE, Minister of Health.
go8074
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Budenocort 200
Active Ingredient: Budesonide 200Β΅g/dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Ayios Athanassios Industrial Estate, Limassol, Cyprus
Product: Budenocort 400
Active Ingredient: Budesonide 400Β΅g/dose
Dosage Form: Powder for inhalation
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Medochemie Limited, Ayios Athanassios Industrial Estate, Limassol, Cyprus
Product: DP-Anastrozole
Active Ingredient: Anastrozole 1mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Douglas Manufacturing Limited, Lincoln, Auckland
Dated this 14th day of November 2007.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go8003
Consent to the Distribution of New Related Products
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
Product: Macleans White and Shine Berry Fresh
Active Ingredient: Sodium fluoride 0.221%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: GlaxoSmithKline Australia Pty Limited, Consumer Healthcare, Ermington, New South Wales, Australia
Product: Vicks Vapodrops Honey Fresh
Active Ingredient: Menthol 0.125%w/w
Dosage Form: Lozenge
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble GmbH, Gross Gerau, Germany
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 127
Gazette.govt.nz —
NZ Gazette 2007, No 127
β¨ LLM interpretation of page content
π₯ Appointment to the Crown Health Financing Agency
π₯ Health & Social Welfare12 November 2007
Appointment, Crown Health Financing Agency, Board Member
- Andrew John Anderson, Appointed as a member of the board
- HON. DAVID CUNLIFFE, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare14 November 2007
Medicines, Distribution, Consent, Budenocort, DP-Anastrozole
- ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to the Distribution of New Related Products
π₯ Health & Social Welfare14 November 2007
Medicines, Distribution, Consent, Macleans, Vicks Vapodrops
- ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate